Last information regarding BMSN was Company holds 12.2 % of the equity and 59% of the voting power of Regen BioPharma.
For comparision
Means BMSN's part of RGBP was decreased 3.4% for commons and prefs and voting power was decreased 6.7% between Dec. 2015 and June 2016. I don't think that Koos sold these parts completely, but i'm sure both parts were further decreased in the last 6 months. We'll have to wait for yearly financials which are due end of December or mid January 2017 in case of a late filing for BMSN.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.